EN DE
Watch Scworx Corp for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Scworx Corp (WORX) fair value: what the stock is really worth

As of Oct 26, 2026: fair value (intrinsic value) of Scworx Corp stock $4.32, price $2.05, upside +110.6%, quality 40 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare · US · ISIN US78396V3078

SC Scworx Corp logo Thin data Oct 25, 2026

Scworx Corp

WORX · US

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

The stock costs 53% less than our calculation considers fair.

Fair value $4.32 · Strongly undervalued (53%)
Low debt
Quality 40/100
Mixed vs. peers (5/11)
Weak Growth (revenue 5y −11.2 %/yr in USD)
Loss-making · -80.5% net margin (TTM)
Negative free cash flow
Narrow moat 8/100 · thin data
Thin data
Watch Scworx Corp for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$10,314 $1.38 Fair Value $4.32 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 25, 2026.

How to read this chart

60‑month range $1.38 – $10,314 · fair‑value band $3.31 – $5.32 · the $2.05 price screens below the $4.32 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 25, 2026.

Follow Scworx in your weekly email

Every Wednesday you see whether Scworx is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

SCWorx Corp., together with its subsidiaries, provides data content and services related to the repair, normalization and interoperability of information for healthcare providers in the United States.

Show moreShow less

The company develops and markets healthcare information technology solutions and associated services that improve healthcare processes and information flow within hospitals and other healthcare facilities.

Its software modules perform separate functions; electronic medical record management; charge description master management; contract management; request for proposal automation; integration of acquired businesses; rebate management; big data analytics model; and data integration and warehousing.

The company sells its solutions and services to hospitals and health systems through a direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in Middleton, Massachusetts.

Stock analysis

Scworx Corp (WORX) currently trades at $2.05, while our model-based Fair Value estimate is $4.32, implying the stock looks roughly 52.5% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 96/100, which puts the data coverage at low.

Scenario range: $3.31 (bear) to $5.32 (bull), the price of $2.05 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 40/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Scworx Corp reported revenue of $2.9M in FY2025 versus $4.6M in FY2021, a compound −11.2%/yr. Reported net income was −$4.4M in FY2025.

Key figures

Market cap $373K Micro · P/E ratio 0.2 · P/S ratio 0.13 · EPS (TTM) $27.02 · Return on equity −38.1% · Return on assets (EBIT) −24.0% · Operating margin −17.1% · Revenue (TTM) $2.9M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).

What moves the price

The share trades about 97% below its 52-week high and 49% above its 52-week low.

For context, the median of 10 Healthcare peers we cover trades at 0% fair-value upside, at 111%, WORX screens cheaper than that median.

Fair Value models

Bear $3.31 Fair Value $4.32 Bull $5.32
Price $2.05 · Upside +110.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($22.21 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EV/EBITDA $3.31 $4.32 $5.32 67
NCAV (Graham) $0.1480 $0.2241 $0.2803 54
All 2 models by family
Multiples
EV/EBITDA $3.31 $4.32 $5.32 67
Asset-Based
NCAV (Graham) $0.1480 $0.2241 $0.2803 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 40/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 8
How much profit the company makes from its sales and capital
Quality Growth 21
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 67
Debt, balance sheet and risk of trouble
Investment 97
Does it invest with discipline instead of growing at any price?
Low Volatility 17
How calm the share price moves, does not count
Momentum 0
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 1
Distance to the 52-week high, does not count
New shares 77
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−3.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−10.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.2%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−116.0% (2020) → −33.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch WORX, get fair value alerts →

Compare Scworx Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 119 stocks

Beats the industry median on 5/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 40 · Bottom 25%
Fair Value upside +110.6% · Top 25%
Profitability
Return on assets −56.3% · Bottom 25%
Net margin (12 months) −80.5% · Bottom 25%
Operating margin (12 months) −17.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 3.4% · Below median
Balance sheet
Debt / equity 0.00× · Below median

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/E (12 months) 0.2× · Cheapest 25%
P/B 0.05× · Cheapest 25%
P/S (12 months) 0.13× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 0
FUTURE (revenue growth)17 · sector 40
PAST (return on equity)0 · sector 12
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)0 · sector 43

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Veeva Systems Inc VEEV $323.04 $355.34 +10% vs WORX
HealthEquity, Inc HQY $103.97 $114.37 +10% vs WORX
Doximity, Inc DOCS $33.39 $36.73 +10% vs WORX
Inventurus Knowledge Solutions Limited IKS ₹1,618 ₹1,780 +10% vs WORX
Waystar Holding WAY $28.98 $29.10 +0% vs WORX
Winning Health Technology Group 300253 ¥7.32 ¥3.44 −53% vs WORX
Hinge Health, Inc HNGE $112.00 $51.25 −54% vs WORX
Pro Medicus Limited PME A$193.42 A$85.12 −56% vs WORX
BrightSpring Health Services, Inc BTSG $62.36 $25.86 −59% vs WORX
Privia Health Group PRVA $22.41 $5.52 −75% vs WORX

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Scworx Corp · Fair Value
$4.32 +53%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Scworx Corp Fair Value". https://www.fairvalue-calculator.com/stock/WORX

Frequently asked questions

Is Scworx Corp (WORX) overvalued or undervalued?
As of Oct 25, 2026, our model estimates a fair value of $4.32 versus a price of $2.05, about +111% upside (undervalued).
What is the fair value of WORX?
Our model-based fair value for Scworx Corp is $4.32 (as of Oct 25, 2026), built from audited fundamentals. The current price: $2.05.
What is the quality score of WORX?
Scworx Corp has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Scworx Corp (WORX)?
Our model-based price target is the fair value of $4.32 (as of Oct 25, 2026) from 2 valuation models. Cautious scenario $3.31, optimistic scenario $5.32. It is a calculation from audited fundamentals, not an analyst target.
What is the Scworx Corp stock forecast for 2026?
Our models put fair value at $4.32, about +111% upside versus a price of $2.05 (undervalued). Cautious scenario $3.31, optimistic scenario $5.32. The calculation is refreshed regularly with new filings.
What is the revenue of Scworx Corp (WORX)?
Scworx Corp reported trailing-twelve-month revenue of about $2.9M (latest available figure, as of Oct 25, 2026).
What is the intrinsic value of Scworx Corp (WORX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Scworx Corp it is $4.32 per share (as of Oct 25, 2026), against a price of $2.05. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is Scworx Corp stock overvalued or undervalued in 2026?
As of Oct 25, 2026, WORX trades below its calculated fair value: price $2.05, fair value $4.32, a gap of about +111% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of WORX?
No. The price is what the market pays today ($2.05); the fair value is what the company's own numbers justify ($4.32). For Scworx Corp the two are $2.27 per share apart. That gap is exactly why we show both numbers side by side.
How much is Scworx Corp worth?
The market values Scworx Corp at about $373K (market capitalisation, as of Oct 25, 2026). Per share that is $2.05; our models calculate a fair value of $4.32 per share.
What do the bullish and bearish scenarios say about WORX?
Our models span a range for Scworx Corp: cautious scenario $3.31, base $4.32, optimistic $5.32 per share (as of Oct 25, 2026, price $2.05). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of WORX?
Scworx Corp trades at a price-to-earnings ratio of 0.2 (as of Oct 25, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $4.32 is built from several models across several years. Other multiples: P/B 0.1, P/S 0.1.
How solid is the balance sheet of Scworx Corp (WORX)?
Balance-sheet figures for Scworx Corp (as of Oct 25, 2026): return on equity −38.1%, debt of 0.00 per unit of equity. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is WORX from its 52-week high?
Scworx Corp trades at $2.05, about 97% below its 52-week high of $77.22 and 49% above the low of $1.38 (as of Oct 26, 2026). Distance from the high says nothing about value: that is what the fair value of $4.32 is for.
Which stocks are comparable to Scworx Corp?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Scworx Corp stock attractive at the current price?
The data as of Oct 25, 2026: price $2.05, calculated fair value $4.32 (+111%), Quality Score 40/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of WORX calculated?
We run Scworx Corp through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $4.32, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.7 % above its aggregate fair value. Scworx Corp currently trades 53 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Scworx Corp (WORX)?
The closing price on Oct 26, 2026 was $2.05. Our model-based fair value is $4.32, about +111% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Scworx Corp right now?
The large discount to fair value meets weak quality (40/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($3.31). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Scworx Corp

How large is the market capitalisation of Scworx Corp (WORX)?
The market capitalisation of Scworx Corp is $373K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Scworx Corp (WORX)?
The price-to-sales ratio of Scworx Corp is 0.13 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Scworx Corp (WORX)?
Earnings per share at Scworx Corp are $27.02 (price ÷ EPS = P/E 0.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Scworx Corp (WORX)?
The return on equity (ROE) of Scworx Corp is −38.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Scworx Corp (WORX)?
On an EBIT basis the return on assets of Scworx Corp is −24.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Scworx Corp (WORX)?
The operating margin of Scworx Corp is −17.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Scworx Corp (WORX)?
Revenue at Scworx Corp is growing +3.4% versus a year earlier (3y avg −10.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Scworx Corp (WORX) generate?
The free cash flow of Scworx Corp is −$1.6M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Scworx Corp (WORX) hold?
Scworx Corp holds more cash than debt, $1.6M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Scworx Corp in the live analysis

One click puts Scworx Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.